Related factors and treatment of community acquired pneumonia in diabetic patients
糖尿病患者并发社区获得性肺炎的相关因素及治疗措施

摘要

目的 分析糖尿病患者并发社区获得性肺炎的相关因素和治疗方法。方法 选择我院2019年-2020年糖尿病患者并发社区获得性肺炎30例为研究对象，选择2019年-2020年单纯性糖尿病患者30例为参照对象，分析年糖尿病患者并发社区获得性肺炎相关因素，并根据相关因素，制定相应的治疗措施。结果 糖尿病患者并发社区获得性肺炎的相关因素有高龄、肺部基础性疾病以及HbAC1，（P<0.05）为差异显著，有统计学意义。患者治疗后TNF-a水平,IL-8水平,NF-KB水平、IL-6水平、CRP水平明显降低，（P<0.05）为差异显著，有统计学意义。结论 积极控制血糖，稳定基础疾病，能够降低社区获得性肺炎发生率。阿奇霉素联合头孢他啶治疗糖尿病患者并发社区获得性肺炎效果较明显，值得临床重视并采纳。

Abstract

Objective: To analyze the related factors and treatment of community-acquired pneumonia in patients with diabetes.
Methods: 30 patients with diabetes complicated with community-acquired pneumonia in our hospital from 2019 to 2020 were selected as the research object, and 30 patients with simple diabetes from 2019 to 2020 were selected as the reference object. The relevant factors of diabetes patients complicated with community-acquired pneumonia in were analyzed, and the corresponding treatment measures were formulated according to the relevant factors.
Results: The related factors of diabetes patients complicated with community-acquired pneumonia were old age, basic pulmonary diseases and HbAc1 (P < 0.05), which were statistically significant. After treatment, the levels of TNF-a, IL-8, NF-kB, IL-6 and CRP in the patients were significantly decreased (P < 0.05), which was statistically significant.
Conclusion  : actively controlling blood glucose and stabilizing basic diseases can reduce the incidence of community-acquired pneumonia. Azithromycin combined with ceftazidime is effective in the treatment of diabetes patients complicated with community-acquired pneumonia, which is worthy of clinical attention and adoption.